Skip to search formSkip to main contentSkip to account menu

rifandin

Known as: 3-(1-isobutyl-1-piperazinyl)rifamycin SV 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

R 761

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A Study of the Animal's Cation Drug Xyalzole Electrode Using a Rifandin as Carrier
The drug xyalzole electrode using a rifanpicin as carrier was made.In 10-2 mol/L NaCl sol-ution aroud pH 4.00～9.00,the response… 
1994
1994
[Development and use of antitubercular biocompatible implants for the treatment of tuberculous spondylitis].
The paper deals with the experimental and clinical study of a new implantable therapeutical means based on biocompatible implants… 
1994
1994
Efficacies of two dosages of rifandin in intensive treatment of pulmonary tuberculosis
1989
1989
STUDY ON RELATIONSHIP BETWEEN BIOAVAILABILITY AND CRYSTALLINE FORMS AS WELL AS DOSAGE FORMS OF RIFANDIN
Rifandin (isobutyl-piperaginyl-rifamycin SV) is a polymorphousCompound with at least four types. The experiments showed that its… 
1988
1988
[Effect of rifandin on the pharmacokinetics of dexamethasone in rabbits determined by reversed phase HPLC].
Rabbits in pairs ware randonly divided into two groups, a group given rifandin and a control group. After a single iv injection… 
1985
1985
Effect of rifandin on ultrastructure of tubercle bacilli.
1985
1985
Effect of rifandin on ultrastructure of tubercle bacilli.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)